Cognition Therapeutics, Inc. (CGTX)
NASDAQ: CGTX · IEX Real-Time Price · USD
1.840
-0.100 (-5.15%)
At close: Jul 19, 2024, 4:00 PM
1.790
-0.050 (-2.72%)
Pre-market: Jul 20, 2024, 9:28 AM EDT
Cognition Therapeutics Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for CGTX stock have an average target of 9.17, with a low estimate of 5.00 and a high estimate of 14. The average target predicts an increase of 398.37% from the current stock price of 1.84.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for CGTX stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 2 | 2 | 3 | 4 | 5 |
Buy | 2 | 1 | 1 | 1 | 1 | 1 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 3 | 3 | 3 | 4 | 5 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Rodman & Renshaw | Rodman & Renshaw | Strong Buy Reiterates $14 | Strong Buy | Reiterates | $14 | +660.87% | Jul 2, 2024 |
Chardan Capital | Chardan Capital | Strong Buy Initiates $11 | Strong Buy | Initiates | $11 | +497.83% | Jun 6, 2024 |
HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $10 | Strong Buy | Initiates | $10 | +443.48% | May 29, 2024 |
B. Riley Securities | B. Riley Securities | Strong Buy Reiterates $5 | Strong Buy | Reiterates | $5 | +171.74% | Mar 28, 2024 |
Oppenheimer | Oppenheimer | Buy Maintains $9 | Buy | Maintains | $9 | +389.13% | Mar 27, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.99
from -0.86
EPS Next Year
-1.08
from -0.99
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | n/a | 44.0M | 151.0M |
Avg | n/a | n/a | n/a | 10.7M | 78.8M |
Low | n/a | n/a | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | 1,312.5% |
Avg | - | - | - | - | 637.2% |
Low | - | - | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -0.61 | -0.40 | -0.48 | -0.82 | -0.75 |
Avg | -0.99 | -1.08 | -1.53 | -1.39 | -0.74 |
Low | -1.34 | -1.84 | -2.78 | -1.90 | -0.74 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.